A single dose study of nabilone, a synthetic cannabinoid

Area of Science:

• Psychopharmacology
• Neuroscience

Background:

• Anxiety disorders are prevalent and often treated with various medications.
• Synthetic cannabinoids are being explored for potential therapeutic applications.
• Nabilone is a synthetic cannabinoid with known psychoactive effects.

Purpose of the Study:

• To investigate the effects of single oral doses of nabilone on anxious subjects.
• To assess nabilone's impact on subjective mood, behavior, and physiological parameters.

Main Methods:

• A single-blind, balanced Latin square design was employed with four anxious subjects.
• Subjects received placebo and three dose levels of nabilone (1-5 mg) at weekly intervals.
• Subjective effects were measured using the Profile of Mood States (POMS), and behavioral effects were assessed via a continuous avoidance procedure.

Main Results:

• High doses (4-5 mg) of nabilone induced significant orthostatic hypotension and dose-related increases in heart rate.
• Subjective sedation was pronounced, but nabilone did not significantly alter behavior in the continuous avoidance task.
• Low doses (1-2 mg) showed a trend towards anti-anxiety effects in some individuals, but this was not statistically significant for the group.

Conclusions:

• Nabilone at higher doses causes significant physiological side effects in anxious individuals.
• Despite subjective sedation, nabilone demonstrated limited efficacy in reducing anxiety or improving performance on a behavioral task.
• Further research may be needed to explore lower doses or different administration routes for potential anxiolytic effects.